ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2018

Natalizumab reduces serum pro-angiogenic activity in MS patients.

Pietro Iaffaldano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.